| RS1602891688 |
AMMECR1
|
Health Risk |
Likely pathogenic |
— |
| RS1602893221 |
PRPS1
|
Health Risk |
Likely pathogenic |
— |
| RS1602901832 |
PRPS1
|
Health Risk |
Likely pathogenic |
Phosphoribosylpyrophosphate synthetase superactivity, Thyroid cancer |
| RS1602903591 |
DEPDC5
|
Health Risk |
Pathogenic |
Familial focal epilepsy with variable foci, Familial focal epilepsy with variable foci |
| RS1602904530 |
OFD1
|
Health Risk |
Likely pathogenic |
Orofaciodigital syndrome I, Orofaciodigital syndrome I |
| RS1602928108 |
KDM6A
|
Health Risk |
Pathogenic |
Kabuki syndrome 2, Kabuki syndrome 2 |
| RS1602928572 |
KDM6A
|
Health Risk |
Likely pathogenic |
Kabuki syndrome 2, Kabuki syndrome 2 |
| RS1602937725 |
DMD
|
Health Risk |
Pathogenic |
— |
| RS1602937895 |
NSDHL
|
Health Risk |
Likely pathogenic |
Child syndrome, Child syndrome |
| RS1602937974 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS1602938385 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS1602942625 |
OFD1
|
Health Risk |
Likely pathogenic |
Orofaciodigital syndrome I, Orofaciodigital syndrome I |
| RS1602947628 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS1602961831 |
NEFH
|
Health Risk |
Likely pathogenic |
Charcot-Marie-Tooth disease axonal type 2C, Charcot-Marie-Tooth disease axonal type 2C |
| RS1602965271 |
KDM6A
|
Health Risk |
Pathogenic |
— |
| RS1602975122 |
HDAC8
|
Health Risk |
Likely pathogenic |
Cornelia de Lange syndrome 5, Cornelia de Lange syndrome 5 |
| RS1602975455 |
HDAC8
|
Health Risk |
Likely pathogenic |
Cornelia de Lange syndrome 5, Cornelia de Lange syndrome 5 |
| RS1602975601 |
HDAC8
|
Health Risk |
Pathogenic |
Cornelia de Lange syndrome 5, Cornelia de Lange syndrome 5 |
| RS1602977573 |
STAG2
|
Health Risk |
Pathogenic |
Mullegama-Klein-Martinez syndrome, Mullegama-Klein-Martinez syndrome |
| RS1602979414 |
ATRX
|
Health Risk |
Likely pathogenic |
Alpha thalassemia-X-linked intellectual disability syndrome, Alpha thalassemia-X-linked intellectual disability syndrome |
| RS1602979818 |
ATRX
|
Health Risk |
Conflicting classifications of pathogenicity |
Alpha thalassemia-X-linked intellectual disability syndrome, Alpha thalassemia-X-linked intellectual disability syndrome |
| RS1602981402 |
BGN
|
Health Risk |
Likely pathogenic |
— |
| RS1602981441 |
BGN
|
Health Risk |
Likely pathogenic |
Meester-Loeys syndrome, Meester-Loeys syndrome |
| RS1602985802 |
KDM6A
|
Health Risk |
Likely pathogenic |
Kabuki syndrome 2, Kabuki syndrome 2 |
| RS1602991098 |
DLG3
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS1602996115 |
ATRX
|
Health Risk |
Pathogenic |
Alpha thalassemia-X-linked intellectual disability syndrome, Alpha thalassemia-X-linked intellectual disability syndrome |
| RS1602996815 |
TIMM8A
|
Health Risk |
Likely pathogenic |
Deafness dystonia syndrome, Inborn genetic diseases |
| RS1603001771 |
BTK
|
Health Risk |
Pathogenic |
X-linked agammaglobulinemia, X-linked agammaglobulinemia |
| RS1603001805 |
BTK
|
Health Risk |
Likely pathogenic |
X-linked agammaglobulinemia with growth hormone deficiency, X-linked agammaglobulinemia |
| RS1603001846 |
BTK
|
Health Risk |
Pathogenic |
X-linked agammaglobulinemia with growth hormone deficiency, X-linked agammaglobulinemia with growth hormone deficiency |
| RS1603002341 |
BTK
|
Health Risk |
Pathogenic |
X-linked agammaglobulinemia with growth hormone deficiency, X-linked agammaglobulinemia with growth hormone deficiency |
| RS1603002367 |
BTK
|
Health Risk |
Pathogenic |
X-linked agammaglobulinemia with growth hormone deficiency, X-linked agammaglobulinemia with growth hormone deficiency |
| RS1603002421 |
BTK
|
Health Risk |
Likely pathogenic |
X-linked agammaglobulinemia with growth hormone deficiency, X-linked agammaglobulinemia with growth hormone deficiency |
| RS1603003195 |
BTK
|
Health Risk |
Pathogenic |
X-linked agammaglobulinemia with growth hormone deficiency, X-linked agammaglobulinemia with growth hormone deficiency |
| RS1603004481 |
BTK
|
Health Risk |
Pathogenic |
X-linked agammaglobulinemia with growth hormone deficiency, X-linked agammaglobulinemia with growth hormone deficiency |
| RS1603004514 |
BTK
|
Health Risk |
Likely pathogenic |
X-linked agammaglobulinemia with growth hormone deficiency, X-linked agammaglobulinemia with growth hormone deficiency |
| RS1603005060 |
BTK
|
Health Risk |
Likely pathogenic |
— |
| RS1603005073 |
BTK
|
Health Risk |
Pathogenic |
X-linked agammaglobulinemia with growth hormone deficiency, X-linked agammaglobulinemia with growth hormone deficiency |
| RS1603005139 |
BTK
|
Health Risk |
Pathogenic |
X-linked agammaglobulinemia with growth hormone deficiency, X-linked agammaglobulinemia with growth hormone deficiency |
| RS1603005659 |
BTK
|
Health Risk |
Likely pathogenic |
X-linked agammaglobulinemia, X-linked agammaglobulinemia with growth hormone deficiency |
| RS1603007888 |
BTK
|
Health Risk |
Pathogenic |
Inherited Immunodeficiency Diseases, Inherited Immunodeficiency Diseases |
| RS1603007942 |
BTK
|
Health Risk |
Pathogenic/Likely pathogenic |
X-linked agammaglobulinemia with growth hormone deficiency, X-linked agammaglobulinemia |
| RS1603008329 |
BTK
|
Health Risk |
Conflicting classifications of pathogenicity |
Inherited Immunodeficiency Diseases, X-linked agammaglobulinemia with growth hormone deficiency |
| RS1603008349 |
BTK
|
Health Risk |
Pathogenic |
X-linked agammaglobulinemia with growth hormone deficiency, X-linked agammaglobulinemia with growth hormone deficiency |
| RS1603008381 |
BTK
|
Health Risk |
Pathogenic |
X-linked agammaglobulinemia, X-linked agammaglobulinemia with growth hormone deficiency |
| RS1603008449 |
BTK
|
Health Risk |
Pathogenic |
X-linked agammaglobulinemia with growth hormone deficiency, X-linked agammaglobulinemia with growth hormone deficiency |
| RS1603009115 |
ZNF711
|
Health Risk |
Pathogenic |
Intellectual disability, X-linked 97 |
| RS1603009890 |
BTK
|
Health Risk |
Pathogenic |
X-linked agammaglobulinemia with growth hormone deficiency, X-linked agammaglobulinemia with growth hormone deficiency |
| RS1603010333 |
BTK
|
Health Risk |
Likely pathogenic |
— |
| RS1603010485 |
BTK
|
Health Risk |
Pathogenic |
X-linked agammaglobulinemia with growth hormone deficiency, X-linked agammaglobulinemia with growth hormone deficiency |
| RS1603014297 |
DEPDC5
|
Health Risk |
Pathogenic |
Familial focal epilepsy with variable foci, Familial focal epilepsy with variable foci |
| RS1603014708 |
DEPDC5
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial focal epilepsy with variable foci, Epilepsy |
| RS1603017538 |
BTK
|
Health Risk |
Pathogenic |
X-linked agammaglobulinemia with growth hormone deficiency, X-linked agammaglobulinemia with growth hormone deficiency |
| RS1603019535 |
BTK
|
Health Risk |
Pathogenic |
X-linked agammaglobulinemia with growth hormone deficiency, X-linked agammaglobulinemia with growth hormone deficiency |
| RS1603019594 |
BTK
|
Health Risk |
Pathogenic |
X-linked agammaglobulinemia, X-linked agammaglobulinemia with growth hormone deficiency |
| RS1603019780 |
BTK
|
Health Risk |
Conflicting classifications of pathogenicity |
X-linked agammaglobulinemia with growth hormone deficiency, X-linked agammaglobulinemia with growth hormone deficiency |
| RS1603020228 |
BTK
|
Health Risk |
Pathogenic |
X-linked agammaglobulinemia with growth hormone deficiency, X-linked agammaglobulinemia with growth hormone deficiency |
| RS1603037323 |
GLA
|
Health Risk |
Pathogenic |
Fabry disease, Fabry disease |
| RS1603037717 |
GLA
|
Health Risk |
Pathogenic/Likely pathogenic |
Primary familial hypertrophic cardiomyopathy, Fabry disease |
| RS1603037764 |
GLA
|
Health Risk |
Pathogenic |
Fabry disease, Fabry disease |
| RS1603038103 |
GLA
|
Health Risk |
Pathogenic |
Fabry disease, Fabry disease |
| RS1603038146 |
AMELX
|
Health Risk |
Pathogenic |
Amelogenesis imperfecta, Amelogenesis imperfecta |
| RS1603038220 |
GLA
|
Health Risk |
Pathogenic/Likely pathogenic |
Fabry disease, Fabry disease |
| RS1603038411 |
GLA
|
Health Risk |
Likely pathogenic |
Primary familial hypertrophic cardiomyopathy, Fabry disease |
| RS1603040008 |
GLA
|
Health Risk |
Conflicting classifications of pathogenicity |
Fabry disease, Fabry disease |
| RS1603040061 |
ATP2B3
|
Health Risk |
Likely pathogenic |
Arthrogryposis multiplex congenita, Fetal akinesia deformation sequence 1 |
| RS1603041916 |
GLA
|
Health Risk |
Pathogenic |
Fabry disease, Fabry disease |
| RS1603047806 |
GLA
|
Health Risk |
Pathogenic |
Fabry disease, Fabry disease |
| RS1603050544 |
SYN1
|
Health Risk |
Pathogenic |
Epilepsy, X-linked 1 |
| RS1603051674 |
SYN1
|
Health Risk |
Pathogenic |
Epilepsy, X-linked 1 |
| RS1603054589 |
GPC4
|
Health Risk |
Likely pathogenic |
GPC4-related disorder, GPC4-related disorder |
| RS1603060007 |
HDAC8
|
Health Risk |
Likely pathogenic |
Intellectual disability, Intellectual disability |
| RS1603068073 |
KDM6A
|
Health Risk |
Likely pathogenic |
Kabuki syndrome 2, Kabuki syndrome 2 |
| RS1603069440 |
HDAC8
|
Health Risk |
Pathogenic/Likely pathogenic |
Intellectual disability, Intellectual disability |
| RS1603078587 |
SYN1
|
Health Risk |
Likely pathogenic |
Epilepsy, X-linked 1 |
| RS1603078614 |
SYN1
|
Health Risk |
Pathogenic |
— |
| RS1603083122 |
CFP
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1603083173 |
CFP
|
Health Risk |
Pathogenic |
— |
| RS1603083434 |
HDAC8
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual disability, Intellectual disability |
| RS1603105985 |
BCORL1
|
Health Risk |
Likely pathogenic |
Shukla-Vernon syndrome, Shukla-Vernon syndrome |
| RS1603113792 |
BCORL1
|
Health Risk |
Likely pathogenic |
Multiple myeloma, Multiple myeloma |
| RS1603123976 |
MTM1
|
Health Risk |
Pathogenic |
Severe X-linked myotubular myopathy, Severe X-linked myotubular myopathy |
| RS1603124201 |
MTM1
|
Health Risk |
Pathogenic |
Severe X-linked myotubular myopathy, Severe X-linked myotubular myopathy |
| RS1603137168 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS1603149954 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS1603150335 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS1603150613 |
STAG2
|
Health Risk |
Conflicting classifications of pathogenicity |
Mullegama-Klein-Martinez syndrome, Mullegama-Klein-Martinez syndrome |
| RS1603150993 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS1603151699 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS1603180742 |
TCEAL1
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1603184989 |
MTM1
|
Health Risk |
Pathogenic |
Severe X-linked myotubular myopathy, MTM1-related disorder |
| RS1603185038 |
MTM1
|
Health Risk |
Pathogenic |
— |
| RS1603192748 |
MTM1
|
Health Risk |
Pathogenic |
— |
| RS1603198063 |
SLC9A6
|
Health Risk |
Pathogenic |
Christianson syndrome, Christianson syndrome |
| RS1603198937 |
SLC9A6
|
Health Risk |
Pathogenic |
Intellectual disability, Intellectual disability |
| RS1603201557 |
SLC9A6
|
Health Risk |
Likely pathogenic |
Christianson syndrome, Christianson syndrome |
| RS1603201598 |
SLC9A6
|
Health Risk |
Likely pathogenic |
— |
| RS1603214377 |
SLC6A8
|
Health Risk |
Pathogenic |
— |
| RS1603215013 |
SLC6A8
|
Health Risk |
Likely pathogenic |
Creatine transporter deficiency, Creatine transporter deficiency |
| RS1603215223 |
SLC6A8
|
Health Risk |
Likely pathogenic |
Creatine transporter deficiency, Creatine transporter deficiency |